Canton Strategic Holdings (CNTN) Interest & Investment Income (2023 - 2026)
Canton Strategic Holdings (CNTN) posted Interest & Investment Income of $318178.0 for Q1 2026, up 1203.05% on a QoQ basis from $24418.0 in Q4 2025, and up 2268.1% year-over-year from $13436.0 in Q1 2025.
Canton Strategic Holdings (CNTN) Interest & Investment Income (2023 - 2026) Analysis & Trends
Canton Strategic Holdings' Interest & Investment Income history runs 4 years deep, the most recent figure standing at $318178.0 for Q1 2026.
- Quarterly Interest & Investment Income rose 2268.1% year-over-year to $318178.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $346152.0 (up 106.72% YoY) and the FY2025 annual result came in at $41410.0, down 83.43% from the prior year.
- Interest & Investment Income was $318178.0 for Q1 2026 at Canton Strategic Holdings, up from $24418.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $318178.0 in Q1 2026 and bottomed at $1388.0 in Q3 2025.
- A 4-year average of $58625.2 and a median of $32248.0 in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2025 — Interest & Investment Income tumbled 98.09% — and 2026, when it jumped 2268.1%.
- Canton Strategic Holdings' Interest & Investment Income stood at $57733.0 in 2023, then plunged by 52.07% to $27672.0 in 2024, then fell by 11.76% to $24418.0 in 2025, then surged by 1203.05% to $318178.0 in 2026.
- Business Quant data shows CNTN's Interest & Investment Income at $318178.0 in Q1 2026, $24418.0 in Q4 2025, and $1388.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Canton Strategic Holdings | 425.80 Mn | 425.80 Mn | - | 318,178.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 318,178.00 |
| Dec 31, 2025 | 24,418.00 |
| Sep 30, 2025 | 1,388.00 |
| Jun 30, 2025 | 2,168.00 |
| Mar 31, 2025 | 13,436.00 |
| Dec 31, 2024 | 27,672.00 |
| Sep 30, 2024 | 72,728.00 |
| Jun 30, 2024 | 53,614.00 |
| Mar 31, 2024 | 95,894.00 |
| Dec 31, 2023 | 57,733.00 |
| Sep 30, 2023 | 28,451.00 |
| Jun 30, 2023 | 34,199.00 |
| Mar 31, 2023 | 32,248.00 |